7-124853023-C-T
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM2PP3_ModeratePP5_Very_Strong
The NM_015450.3(POT1):c.818G>A(p.Arg273Gln) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_015450.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
POT1 | NM_015450.3 | c.818G>A | p.Arg273Gln | missense_variant | Exon 10 of 19 | ENST00000357628.8 | NP_056265.2 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Tumor predisposition syndrome 3 Pathogenic:3
Variant absent from gnomADv4. Variant identified in a patient with clinical/familial history consistent with POT1 variant. Amino acid conserved in evolution. At the same amino acid position, another variant (c.818G>T; p.Arg273Leu) is considered pathogenic (PMID 24686849). -
- -
This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 273 of the POT1 protein (p.Arg273Gln). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with POT1-related conditions (internal data). ClinVar contains an entry for this variant (Variation ID: 475105). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed for this missense variant. However, the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on POT1 protein function. Studies have shown that this missense change is associated with inconclusive levels of altered splicing (internal data). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
Long telomere syndrome Pathogenic:1
- -
Hereditary cancer-predisposing syndrome Pathogenic:1
The p.R273Q variant (also known as c.818G>A), located in coding exon 6 of the POT1 gene, results from a G to A substitution at nucleotide position 818. The arginine at codon 273 is replaced by glutamine, an amino acid with highly similar properties. This alteration was associated with long telomere length which conferred a predisposition to familial clonal hematopoiesis syndrome (DeBoy EA et al. N Engl J Med, 2023 Jun;388:2422-2433). This alteration has been observed in multiple individuals with a personal and family history that is consistent with POT1-related disease (Ambry internal data and personal communication). This amino acid position is highly conserved in available vertebrate species. Based on the majority of available evidence to date, this variant is likely to be pathogenic. -
not provided Uncertain:1
Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 28393830, 24686849) -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at